This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Pomegranate
DrugBank Accession Number
DB14317
Background

Pomegranate is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Experimental, Investigational
Synonyms
  • Ae-pomegrante
  • Allergenic Extract- Pomegranate Punica Granatum
  • Dadima Fruit
  • Pomegranate Extract
  • Pomegranate Fruit
  • Pomegranate Fruit Polyphenol Extract
  • Pomegranates, Raw
  • Pomegranates,raw
  • Punica Granatum Fruit
  • Punica Granatum Fruit Extract
  • Shi Liu Fruit

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Red CleoJelly44.335 g/100gOralHLscience Co Ltd2016-04-052018-02-12US flag
Red CleoLiquid1 mg/1mLTopicalHealth-Love Co.2013-07-022017-01-01US flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Frudia Pomegranate Nutri Moisturizing MaskPomegranate (12.57 g/27mL) + Adenosine (0.01 g/27mL)PatchTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing SerumPomegranate (31.99 g/50g) + Adenosine (0.02 g/50g)CreamTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing TonerPomegranate (170.7 g/195mL) + Adenosine (0.07 g/195mL)LiquidTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Frudia Pomegranate Nutri Moisturizing MaskPomegranate (12.57 g/27mL) + Adenosine (0.01 g/27mL)PatchTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing SerumPomegranate (31.99 g/50g) + Adenosine (0.02 g/50g)CreamTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing TonerPomegranate (170.7 g/195mL) + Adenosine (0.07 g/195mL)LiquidTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Red CleoPomegranate (44.335 g/100g)JellyOralHLscience Co Ltd2016-04-052018-02-12US flag
Red CleoPomegranate (1 mg/1mL)LiquidTopicalHealth-Love Co.2013-07-022017-01-01US flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
56687D1Z4D
CAS number
Not Available

References

General References
Not Available
RxNav
1246101
Wikipedia
Pomegranate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentOral Lichen Planus1
2Active Not RecruitingTreatmentSyndrome, Metabolic1
2CompletedPreventionPSA Level Less Than or Equal to Fifteen / PSA Level Less Than Ten / Stage I Prostate Cancer AJCC v7 / Stage II Prostate Cancer AJCC v7 / Stage IIA Prostate Cancer AJCC v7 / Stage IIB Prostate Cancer AJCC v71
2TerminatedTreatmentCardiomyopathy / Heart Failure1
2Unknown StatusTreatmentFollicular Lymphoma ( FL)1
1RecruitingTreatmentSkin and Subcutaneous Tissue Disorders1
1Unknown StatusTreatmentBenign Prostatic Hyperplasia (BPH)1
Not AvailableCompletedPreventionGingivitis1
Not AvailableCompletedTreatmentProstate Cancer1
Not AvailableUnknown StatusTreatmentAtherosclerosis / Diabetes Mellitus1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
PatchTopical
CreamTopical
LiquidTopical
JellyOral44.335 g/100g
LiquidTopical1 mg/1mL
CapsuleOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53